| Group A (n = 34) | Group B (n = 34) | P |
---|---|---|---|
Age, (years, mean ± SD) | 60.44 ± 3.58 | 65.83 ± 3.04 | < 0.001 |
Male/female | 19/15 | 21/13 | ns |
Diagnoses (n) | CAP (34) | • TB (2) | - |
 | • Streptococcus pneumoniae (4) | • Lung cancer (13) |  |
 | • Staphulococcus aureus (3) | • Pulmonary embolism (6) |  |
 | • Haemophilus influenzae (2) | • Congestive heart failure (5) |  |
 | • Pseudomonas aeruginosa (2) | • Interstitial lung disease (6) |  |
 | • Other (4) | • Other (2) |  |
pO2/FiO2 (mean ± SE) | 240.18 ± 20.8 | 314.83 ± 15.9 | 0.006 |
SOFA (mean ± SE) | 3.11 ± 0.43 | 1.66 ± 0.18 | 0.004 |
APACHE II (mean ± SE) | 12.69 ± 1.06 | 9.4 ± 1.09 | 0.037 |
CPIS (mean ±SE) | 5.38 ± 0.23 | 2.06 ± 0.25 | < 0.001 |
Mortality [n (%)] | 9 (26) | 2 (5.8) | Â |
White blood cells (mean ±SE) | 14172.4 ± 1314.7 | 10470 ± 874.2 | 0.023 |